NCT07186023

Brief Summary

This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Aug 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Aug 2025Dec 2028

Study Start

First participant enrolled

August 1, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

2.8 years

First QC Date

August 14, 2025

Last Update Submit

September 15, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in neural activation related to emotional processing, sensory processing, attention, and memory-related brain regions.

    Significant alterations in blood oxygen level-dependent (BOLD) signal amplitude during task-based functional magnetic resonance imaging (fMRI).

    Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

  • Changes in resting-state functional connectivity within and between brain networks

    Statistically significant alterations in intrinsic functional connectivity parameters derived from blood-oxygen-level-dependent (BOLD) signals acquired during resting-state functional magnetic resonance imaging (rs-fMRI).

    Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

Secondary Outcomes (12)

  • Regional brain morphometric changes, assessed by quantitative analysis of gray matter volume, thickness, and density differences using high-resolution structural magnetic resonance imaging.

    Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

  • Self-reported neuropsychological outcomes assessed through validated Wechsler Adult Intelligence Scale (WAIS).

    Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  • Scores of the total number of category-naming items correctly named within one minute for testing verbal fluency.

    Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  • Changes in the depression scale

    Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  • Changes in anxiety scale

    Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  • +7 more secondary outcomes

Study Arms (4)

MBSR

ACTIVE COMPARATOR

Mindfulness-Based Stress Reduction

Behavioral: MBSR

MBWC

ACTIVE COMPARATOR

Mindfulness-Based Well-Being Curriculum

Behavioral: MBWC

MBCI

ACTIVE COMPARATOR

Mindfulness-Based Curriculum for Insomnia

Behavioral: MBCI

BSI

OTHER

Brain Stimulation Intervention

Device: BSI

Interventions

MBSRBEHAVIORAL

Mindfulness-Based Stress Reduction

MBSR
MBWCBEHAVIORAL

Mindfulness-Based Well-Being Curriculum

MBWC
MBCIBEHAVIORAL

Mindfulness-Based Curriculum for Insomnia

MBCI
BSIDEVICE

Brain Stimulation Intervention

BSI

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Literate or have received an education above the elementary level.
  • Have normal or corrected vision and hearing, able to communicate and understand explanations.
  • Right-handed individuals as assessed by the Edinburgh Handedness Inventory.

You may not qualify if:

  • Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease.
  • Individuals with neurological system disorders.
  • Individuals with alcohol or drug dependence.
  • Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months.
  • Individuals with metal objects in the body that cannot undergo magnetic resonance imaging (MRI), such as cardiac pacemakers, vascular clips, hearing aids, artificial joints, steel pins, etc.
  • Individuals with Claustrophobia.
  • Individuals in pregnancy or possibility of pregnancy.
  • Individuals diagnosed with major depressive disorder by psychiatrists according to the Diagnostic and Statistical Manual, and who can cooperate with the psychiatric outpatient clinic regulations.
  • Literate or have received an education above the elementary level.
  • Have normal or corrected vision and hearing, able to communicate and understand explanations.
  • Right-handed individuals as assessed by the Edinburgh Handedness Inventory.
  • Individuals are prescribed brain stimulation therapy by clinical physicians.
  • Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease.
  • Individuals with neurological system disorders.
  • Individuals with alcohol or drug dependence.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shuang Ho Biomedical Park, Taipei Medical University

New Taipei City, 235603, Taiwan

RECRUITING

National Center for Geriatrics and Welfare Research

Yunlin, 632007, Taiwan

NOT YET RECRUITING

Central Study Contacts

Ai-Ling Hsu, PhD.

CONTACT

Changwei W. Wu, PhD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Investigator

Study Record Dates

First Submitted

August 14, 2025

First Posted

September 22, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations